Introduction: Metabolic syndrome (MetS) is a multifactorial disorder in which dyslipidemia plays an important role. Fatty acid-binding protein 2 (FABP 2) is responsible for transport of free fatty acids in the intestinal endothelium cells. FABP2-genetic variants might aff ect plasma lipid concentrations and intracellular lipid transport. The aim of this study was to investigate the association between FABP2 Ala54Thr genetic polymorphism and metabolic syndrome and some biochemical and anthropological parameters in elderly subjects.
Introduction
Metabolic syndrome (MetS) has become a global health concern over the past few decades, worldwide (1) (2) (3) . General risk factors for developing MetS are abdominal obesity, hypertension, hyperglycemia and dyslipidemia. In addition to these, the characteristics of MetS include proinfl ammatory and prothrombotic state, hyperuricemia and gout, microalbuminuria, and electrolyte disbalance (2, (4) (5) (6) .
Many genetic polymorphisms might be involved in the pathogenesis of MetS (7) . The genes responsible for the metabolism and transport of lipids, regulation of arterial blood pressure, the transport, regulation and metabolism of glucose, hormonal regulation and other factors might contribute to the development of MetS (7) (8) (9) . The fatty acid-binding proteins (FABPs) are members of the superfamily of small (14-15 kDa) intra- (10) . LBPs play various important roles in signaling, regulation, membrane traffi cking, immune response, lipid metabolism and transport (11) . Intestinal fatty acidbinding protein (I-FABP or FABP2) is one of nine diff erent FABPs identifi ed in mammals, besides liver, heart and muscle, adipocyte, epidermal, ileal, brain, myelin and testis FABP (10, 12) . The primary function of all FABPs is the regulation of fatty acid uptake (FA) and intracellular transport.
The genes that encode FABPs are dispersed throughout the genome and their structure is well conserved (13) . Each gene consists of four exons separated by three introns of variable sizes (13) . The FABP2 gene encodes for intestinal fatty acidbinding protein, which is involved in the uptake, intracellular metabolism, and/or transport of long chain fatty acids (13) . The gene consists of 3382 nucleotides located in the chromosomal region 4q28-4q31, arranged in four exons containing ~700 bp and three introns containing ~2650 bp (14, 15) . I-FABP (FABP2) protein consists of 131 amino acid residues and has a high content of β-strand structure. The internal binding cavity is capable of binding one molecule of ligand, with affi nity depending on fatty acid identity (14) . I-FABP (FABP2) has two forms (alanine-containing (A54) or threonine-containing (T54) protein which display diff erences in binding and transporting fatty acids across cells (16) . Polymorphism is due to the transition from G to A at codon 54 of the FABP2 gene and results in a substitution of alanine by threonine (Ala54Thr) in exon 2 (rs1799883). Threoninecontaining protein has greater ability to transport long chain fatty acids than alanine-containing protein (16) . The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene can be commonly found in around 30% of the most populations and is associated with insulin resistance (17), dyslipidemia and obesity (18, 19) , which are all cardinal components of MetS. Three diff erent meta-analyses evaluated the eff ects of the Ala54Thr polymorphism on body mass index (BMI) (20) , insulin resistance (21) and fasting lipids (18) in diff erent world populations. The fi rst analysis showed that there is no association between Ala54Thr polymorphism and BMI (20) . However, weak association appears to be present between this polymorphism and insulin resistance (21) . Finally, strong association was found between the Thr54 allele and higher levels of triglycerides (TGs) and LDL-cholesterol, and lower levels of HDL-cholesterol (18) . As FABP2 is involved in the transport of fatty acids inside intestinal cells and therefore might aff ect the fatty acids composition of chylomicron triglycerides, we hypothesized that this polymorphism might be involved in the pathogenesis of MetS at least as its dyslipidemic component. The aim of this study was to investigate the association between FABP2 Ala54Thr genetic polymorphism and metabolic syndrome and some biochemical and anthropological parameters in elderly subjects.
Materials and methods

Study design
This is a cross-sectional and comparative study, the fi nal step of a large longitudinal national multicenter epidemiological study of chronic diseases in Croatian population, conducted by the researchers and medical team from the Institute for Medical Research and Occupational Health and their collaborators. Study design was already described in details elsewhere (22, 23 
Subjects
The study included 140 men and 176 women whose median age was 78 (range 71-93 years) and 77 (range 71-92 years), respectively. Blood sampling, medical examination and interviews were performed between 07.00 and 12.00 a.m. Height, weight and waist circumference were measured according to the International Biological Program Protocol (25) . Waist circumference was taken on midway between the 10th rib and the top of the iliac crest (at the level of the umbilicus) using a fl exible nonstretchable plastic tape and was approximated to the nearest 0.1 cm. Blood pressure was measured in the sitting position after 10-20 min rest using a mercury sphygmomanometer (Reister, Jungingen, Germany). Hypertension was defi ned as blood pressure ≥ 130/85 mmHg. Mean arterial pressure (MAP) was calculated according to equation: MAP = [(2 x diastolic) + systolic] / 3 (26) . Body mass index (BMI) was calculated according to the formula: mass (kg) / body height (m) 2 . Smoking status was defi ned in line with the questionnaire data: smokers were defi ned as all ex-smokers and active smokers, whereas non-smokers were those that had never smoked.
Blood sampling
Blood samples were collected in the K 2 EDTA tubes and serum separator tubes (BD Vacutainer, Becton Dickinson, Plymouth, UK) by puncture from an antecubital vein after an overnight fasting. Serum samples were stored at -20°C until analyses.
Methods
Serum concentration of glucose, total proteins and C-reactive protein (CRP) were determined by standardized methods on Beckman Coulter AU400 selective autoanalyzer (Beckman Coulter, Tokyo, Japan) using reagents from the same manufacturer (Beckman Coulter, Hamburg, Germany). Lipid parameters (total cholesterol, HDL-cholesterol and triglycerides) were determined with enzymatic methods on the Roche COBAS MIRA autoanalyzer using reagents from Boehringer-Manheim Diagnostics and Hoff mann-La Roche (Roche diagnostics, Mannheim, Germany). LDL-cholesterol was calculated according to the Friedwald formula (27) . DNA was extracted from whole blood by automatized salting out method with a Biosprint 15 DNABlood Kit (Qiagen GmbH, Hilden, Germany) on a KingFisher automatic system (Thermo Labsystems, Helsinki, Finland). FABP2 genetic polymorphism (2445G→A) Ala54Thr was genotyped with PCR-RF-PL method (28), using Hha I restriction endonuclease (Fermentas International Inc., Burlington, Canada). Polymerase chain reactions of exon 2 were performed with primers (Sigma-Aldrich Chimie GmbH, Taufkirchen, Germany), whose sequence was previously described (28 
Results
According to the IDF defi nition of MetS, 68% of a total of 316 subjects involved in the study (Table 1) were aff ected by MetS. As expected, there were signifi cant diff erences in the concentrations of glucose and HDL-cholesterol, as well as in waist circumference values and the frequency of hypertension between MetS(-) and MetS(+) groups. Additionally, the frequency of smokers and the concentrations of CRP were signifi cantly higher in MetS(+) subjects. There was no diff erence in the frequencies of FABP2 Ala54Thr genotypes between the studied groups. The association of genotypes -carriers of 54Thr allele and blood and anthropometrics parameters was performed using t-test or Mann-Whitney-test based on distribution normality. T -total; M -men; W -women. group (P = 0.001), and for both genders (men P = 0.039; women P = 0.004) as compared to Thr54 non-carriers. There is no any diff erence between carriers and non-carriers in subjects without MetS for neither of parameters tested.
Discussion
The results of the present study showed that there is no signifi cant diff erence in the frequency of FABP2 Ala54Thr polymorphism between the subjects with and without MetS according to the IDF criteria. As expected, there is a signifi cant diff erence in lipid parameters between these subjects. Signifi cantly lower TGs and higher HDL-cholesterol mean concentrations in carriers of 54Thr allele as compared to non-carriers indicate that the 54Thr allele might have a protective role in subjects with MetS after an overnight fast. Gender and age as covariates showed a statistically signifi cant but clinically irrelevant eff ect of the Thr54 carriers on total and LDL-cholesterol concentrations, as well as on waist circumference and BMI levels. There are many confl icting conclusions in investigations of Ala54Thr polymorphism and lipid profi le. The reduction in plasma triglyceride level in the carriers of Thr allele was found in sixteen healthy postmenopausal women in a cross-over designed feeding trial in which these women were undergoing a high-fat diet (29) . The lowest values for triglyceride-rich lipoprotein (TRL) cholesterol and TRL phospholipids were found in women homozygous for the Thr54-encoding allele, whereas the highest values were found in men homozygous for the Thr54-encoding allele (30) . This study was designed as a clinical trial involving subjects who were subject to a low-fat American Heart Association-type diet. A Spanish cross-sectional study did not fi nd any diff erence in anthropometric and lipid parameters between genotypes in subjects with or without MetS (19) . The results of our study also showed the lack of association between the Thr54/Ala54 and Thr54/Thr54 FABP2 genotypes and MS. The meta-analysis that included investigations published before June 2009 showed the opposite results for lipid parameters in the fasting state (18) . This meta-analysis involved adults of at least 18 years of age, from diff erent populations, and with diff erent health disorders. Several studies with obese subjects reported that 54Thr allele was not associated with higher TGs or lower HDL-cholesterol fasting concentrations. However, the general conclusion was that 54Thr allele was associated with higher concentrations of TGs and lower concentrations of HDL-cholesterol, which is contradictory to our results. FABP2 Ala54Thr polymorphism may aff ect lipid levels depending on the composition of dietary intake. Chamberlain et al. (17) concluded that limiting dietary saturated fat intake may be particularly important among the carriers of the A allele of FABP2 among young adults. They did not fi nd any diff erence in lipid profi les in the fasting state. A large Japanese case-control study showed that Thr54 represented a risk factor for myocardial infarction in subjects with MetS, although it was related to reduced fasting glucose and total cholesterol concentrations (31) .
In vitro studies showed that FABP2 is responsible for postprandial transport and partitioning of long-chain free fatty acids (FFA) toward TG synthesis (32) . Overexpression of FABP2 in HIEC-6 cells also showed a minor eff ect on monounsaturated fatty acid oxidation. THr54 isoform of FABP2 has higher binding affi nity of substrate oleate and arachidonate than Ala 54 isoform (33) . It can be expected that polymorphisms of FABP2 will not aff ect fasting lipid values because they are responsible for postprandial fatty acid transport. General conclusion might be that literature data are inconsistent and depend on study designs, number of subjects, age, ethnicity, clinical trials etc.
There are several limitations to this investigation. The study included subjects over 70 years of age and the frequency of MetS is higher in older than in younger subjects. Furthermore, previous followups lack data and this might explain dyslipidemia induced by Ala54Thr polymorphism. Determination of free fatty acids (FFA) and composition of FFA also might be useful in explaining the above mentioned polymorphism association with MetS because of diff erent substrate affi nity of genetic variants (14) . The lack of data on lipid concentrations in postprandial state and on subjects who re-ceived statin therapy represents an additional weakness of this study. However, an added value of this study is the fact that this is the fi rst such study on the eff ects of FABP2 Ala54Thr polymorphism in Croatian subjects. Results of this study might contribute to the understanding of pathophisiology of dyslipidemia and MetS, as well as of other related multifactorial disorders.
In conclusion, there is evidence that FABP2 genetic variations alter triglyceride and HDL-cholesterol concentrations in elderly subjects with MetS. These genetic variations might be useful markers for understanding dyslipidemia in MetS.
